This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Abel, E. D. Search for Related Content PubMed PubMed Citation Articles by Abel, E. D. Related Collections Biochemistry and metabolism Animal models of human disease Acute myocardial infarction Chronic ischemic heart disease

(Circulation. 2007;116:884-887.)
© 2007 American Heart Association, Inc.

Editorial

Glucose for the Aging Heart?

E. Dale Abel, MBBS, DPhil

From the Division of Endocrinology, Metabolism, and Diabetes and Program in Human Molecular Biology and Genetics, University of Utah School of Medicine, Salt Lake City.

Correspondence to E. Dale Abel, Division of Endocrinology, Metabolism, and Diabetes, Program in Human Molecular Biology and Genetics, 15 N 2030 E, Bldg 533, Room 3410B, Salt Lake City, UT 84112. E-mail dale.abel@hmbg.utah.edu

Key Words: Editorials • glucose transporter • metabolism • myocardial ischemia

An extract of the first 250 words of the full text is provided, because this article has no abstract.

Aging is associated with increased susceptibility of the heart to ischemia. Many potential reasons for this exist, including increased oxidative stress, mitochondrial dysfunction, and possibly changes in myocardial substrate utilization.^1,2 Given the fact that ischemic heart disease is the leading cause of death in the aging population, strategies that increase the ability of the heart to recover after ischemic insults could have important therapeutic benefits. In a report published in this issue of Circulation, Luptak and colleagues describe the susceptibility of isolated hearts from mice with lifelong overexpression of the GLUT1 glucose transporter to ischemia and reperfusion.³ They report that a long-term increase in glucose utilization limits age-related diastolic dysfunction and is associated with a reduction in ischemic contracture during low-flow ischemia and improved recovery of systolic and diastolic function after reperfusion. Importantly, overexpression of the GLUT1 transgene was associated with reduced rates of depletion of cardiac ATP stores during ischemia that were particularly striking in young mice, higher concentrations of phosphocreatine at baseline in older mice, and a more rapid restoration of high-energy phosphate content in the hearts of young and old transgenic mice after reperfusion. Thus, maintaining high rates of myocardial glucose utilization might retard age-related myocardial dysfunction and promote functional recovery after ischemia.

Article p 901

To maintain high rates of ATP generation, the heart exhibits a remarkable ability to metabolize a variety of metabolic substrates. It is widely accepted that under physiological circumstances, oxidative metabolism of fatty acids accounts for >50% of myocardial ATP generation . . . [Full Text of this Article]

This article has been cited by other articles:

				J. Yoshioka, K. Imahashi, S. A. Gabel, W. A. Chutkow, A. A. Burds, J. Gannon, P. C. Schulze, C. MacGillivray, R. E. London, E. Murphy, et al. Targeted Deletion of Thioredoxin-Interacting Protein Regulates Cardiac Dysfunction in Response to Pressure Overload Circ. Res., December 7, 2007; 101(12): 1328 - 1338. [Abstract] [Full Text] [PDF]